Results 41 to 50 of about 273,405 (257)

Transcatheter Tricuspid Valve Implantation of NaviGate Bioprosthesis in a Preclinical Model

JACC: Basic to Translational Science, 2018
Patients with isolated functional or recurrent tricuspid regurgitation are often denied surgery because they are considered to be at high risk. Transcatheter valve therapy provides a less invasive alternative for tricuspid regurgitation associated with ...
Jose L. Navia, MD, Samir Kapadia, MD, Haytham Elgharably, MD, Gabriel Maluenda, MD, Krzysztof Bartuś, MD, Cristian Baeza, MD, Rajesh K. Nair, MD, Josep Rodés-Cabau, MD, Cesare Beghi, MD, Rodolfo C. Quijano, MD, PhD   +9 more
doaj   +1 more source

Tricuspid Valve Repair for Functional Tricuspid Regurgitation [PDF]

Operative Techniques in Thoracic and Cardiovascular Surgery, 1998
Tricuspid valve insufficiency can be caused by organic disease of the tricuspid valve (rheumatic disease, endocarditis, carcinoid, and so on); however, most tricuspid regurgitation encountered in clinical practice occurs in patients with chronic left-sided valvular lesions.
Gillinov, A. Marc, Cosgrove, Delos M.
openaire   +1 more source

Comparative outcomes and risk analysis after cone repair or tricuspid valve replacement for Ebstein's anomalyCentral MessagePerspective

JTCVS Open, 2023
Objective: Ebstein's anomaly is a rare congenital heart malformation for which surgical and medical management are still controversial. The cone repair has transformed surgical outcomes in many of these patients.
Rebekah Boyd, MD, David Kalfa, MD, PhD, Stephanie Nguyen, MD, Matan Setton, MD, Amee Shah, MD, John Karamichalis, MD, Matthew Lewis, MD, Noa Zemer Wassercug, MD, Marlon Rosenbaum, MD, Emile Bacha, MD   +9 more
doaj   +1 more source

Management of tricuspid valve regurgitation [PDF]

European Journal of Cardio-Thoracic Surgery, 2017
Tricuspid regurgitation (TR) is a very frequent manifestation of valvular heart disease. It may be due to the primary involvement of the valve or secondary to pulmonary hypertension or to the left-sided heart valve disease (most commonly rheumatic and involving the mitral valve).
Antunes, Manuel J, Rodríguez-Palomares, José, Prendergast, Bernard, De Bonis, Michele, Rosenhek, Raphael, Al-Attar, Nawwar, Barili, Fabio, Casselman, Filip, Folliguet, Thierry, Iung, Bernard, Lancellotti, Patrizio, Muneretto, Claudio, Obadia, Jean-François, Pierard, Luc, Suwalski, Piotr, Zamorano, Pepe   +15 more
openaire   +2 more sources

Physiological and clinical consequences of relief of right ventricular outflow tract obstruction late after repair of congenital heart defects. [PDF]

, 2006
BACKGROUND: Right ventricular outflow tract obstruction (RVOTO) is a common problem after repair of congenital heart disease. Percutaneous pulmonary valve implantation (PPVI) can treat this condition without consequent pulmonary regurgitation or ...
Sridharan, S, Schievano, S, Coats, L, Jones, R, Mist, B, Taylor, AM, Deanfield, JE, Bonhoeffer, P, Derrick, G, Khambadkone, S, Pellerin, D   +10 more
core  

KLF5 Downregulation Links Impaired BNIP3‐Mediated Mitophagy to Inflammatory Valve Remodeling in Calcific Aortic Valve Disease

Advanced Science, EarlyView.
In human CAVD, KLF5 is reduced in VIC‐rich regions and remodeling/stress‐associated VIC states. In VICs, KLF5 sustains BNIP3 promoter activity and BNIP3‐mediated mitophagy, thereby limiting cytosolic mtDNA accumulation. KLF5 loss weakens mitochondrial quality control and enhances mtDNA‐sensitive STING/NF‐κB/NLRP3 inflammatory signaling under osteogenic
Jin‐Hui Bian, Jia‐Xi Gu, Zhang Yue, Chun‐Ze Yuan, Hai‐Bin Ji, Ao Li, Yu Zhong, Xiu‐Fan Xu, Yu‐Qiu He, Ye‐Fan Jiang, Hong‐Shan Chen, Xiang Chen, Meng‐Lin Chao, Yong‐Feng Shao   +13 more
wiley   +1 more source

Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß, Philipp Mourikis, Fabian Nienhaus, Jafer Haschemi, Alexander Hoss, Tobias Zeus, Hanna Kowalski, Maximilian Spieker, Christian Jung, Patrick Horn, Hug Aubin, Artur Lichtenberg, Richard Truse, Malte Kelm, Amin Polzin   +14 more
wiley   +1 more source

Prevalence of moderate-to-severe TR suitable for percutaneous intervention in TTE patients

Echo Research and Practice, 2018
Moderate-to-severe tricuspid regurgitation is associated with higher mortality and morbidity yet remains significantly undertreated. The reasons for this are complex but include a higher operative mortality for patients undergoing isolated tricuspid ...
Z H Teoh, J Roy, J Reiken, M Papitsas, J Byrne, M J Monaghan   +5 more
doaj   +1 more source

Isolated or concomitant tricuspid valve surgery for massive or torrential tricuspid regurgitationCentral MessagePerspective

JTCVS Open
Objective: Massive or torrential tricuspid regurgitation is associated with poor survival; however, its impact on surgical results remains uncertain.
Hironobu Sakurai, MD, PhD, Satoshi Kainuma, MD, PhD, Naonori Kawamoto, MD, PhD, Kizuku Yamashita, MD, PhD, Kota Suzuki, MD, PhD, Takashi Kakuta, MD, PhD, Ayumi Ikuta, MD, PhD, Rieko Kutsuzawa, MD, Yuki Tadokoro, MD, Kazuki Miyatani, MD, Shinichi Kurashima, MD, Yuki Irie, MD, Kenji Moriuchi, MD, Masashi Amano, MD, PhD, Atsushi Okada, MD, PhD, Makoto Amaki, MD, PhD, Hideaki Kanzaki, MD, PhD, Takeshi Kitai, MD, PhD, Chisato Izumi, MD, PhD, Kazuhiro Yamamoto, MD, PhD, Satsuki Fukushima, MD, PhD   +20 more
doaj   +1 more source

The Tricuspid Valve [PDF]

Circulation, 2009
Cardiovascular specialists have entered an era of renewed interest and enthusiasm surrounding the diagnosis and treatment of valvular heart disease, driven in part by emerging percutaneous therapies for the treatment of aortic, pulmonic, and mitral valve disease. Despite this wave of investigation, little or no attention has been given to the treatment
Jason H, Rogers, Steven F, Bolling
openaire   +2 more sources